Abstract
The crypt–villus architecture of the intestinal mucosa is underpinned by dynamic interactions between distinct populations of epithelial, stromal and immune cells. Although the epithelial compartment has attracted substantial attention, there is a growing appreciation for the critical role of mesenchymal cells in shaping epithelial stem cell function and dictating lineage specification. In this Review, we outline how the epithelial and mesenchymal compartments of the developing gut evolve in a mutually dependent manner to establish dynamic reciprocal signalling gradients that maintain adult tissue homeostasis. We discuss how perturbations to this delicate ecosystem result in rapid adaptive cellular responses that act to restore tissue function. Furthermore, we explore how the intricate nature of cell fate interdependence also renders the mucosa susceptible to pathological disruption. Drawing on the latest studies, we highlight the crosstalk networks between the epithelial and stromal compartments that underlie these processes and consider how these insights are informing future research directions and therapeutic strategies. In doing so, we advocate for a shift away from the conventional epithelial-centric paradigm toward a more integrated framework that considers the full spectrum of intercellular interactions maintaining intestinal tissue integrity and shaping disease progression.
Key points
-
Epithelial–mesenchymal cell interactions orchestrate crypt–villus morphogenesis during development, establishing a cross-compartmental interdependence that persists through adult life.
-
In health, crypt–villus compartmentalization is maintained by opposing gradients of reciprocal morphogenic signals that collectively pattern epithelial and mesenchymal cell fate and function along the vertical axis.
-
This dynamic bidirectional interplay renders the intestinal mucosa remarkably sensitive to damage, enabling a rapid cascade of coordinated epithelial and mesenchymal remodelling events that drive tissue repair.
-
Mutant intestinal cells must either cooperate with their surrounding niche or subvert existing intercompartmental crosstalk networks to bypass homeostatic constraints in favour of tumorigenesis.
-
Metastatic outgrowth and colonization similarly rely on adaptive interactions with the evolving microenvironment, with resident cells in the host organ co-opted and reprogrammed into supportive pro-metastatic niches.
-
Adopting a systems-level approach that considers the intestinal mucosa as an integrated ecosystem will be needed to unravel the regulatory mechanisms underpinning these processes and guide innovative therapeutic strategies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
McCarthy, N. et al. Distinct mesenchymal cell populations generate the essential intestinal BMP signaling gradient. Cell Stem Cell 26, 391–402.e5 (2020).
Kraiczy, J. et al. Graded BMP signaling within intestinal crypt architecture directs self-organization of the Wnt-secreting stem cell niche. Cell Stem Cell 30, 433–449.e8 (2023). This elegant study illustrates how BMP signals from crypt top fibroblasts create a gradient that spatially patterns mesenchymal cells along the vertical axis, generating a self-organizing WNT-secreting niche at the crypt base that sustains ISC identity.
McCarthy, N., Kraiczy, J. & Shivdasani, R. A. Cellular and molecular architecture of the intestinal stem cell niche. Nat. Cell Biol. 22, 1033–1041 (2020).
Pærregaard, S. I. et al. The small and large intestine contain related mesenchymal subsets that derive from embryonic Gli1+ precursors. Nat. Commun. 14, 2307 (2023).
Kinchen, J. et al. Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease. Cell 175, 372–386.e17 (2018).
Kabiri, Z. et al. Stroma provides an intestinal stem cell niche in the absence of epithelial Wnts. Development 141, 2206–2215 (2014).
Valenta, T. et al. Wnt ligands secreted by subepithelial mesenchymal cells are essential for the survival of intestinal stem cells and gut homeostasis. Cell Rep. 15, 911–918 (2016).
Zhu, G., Hu, J. & Xi, R. The cellular niche for intestinal stem cells: a team effort. Cell Reg. 10, 1 (2021).
McCarthy, N. et al. Smooth muscle contributes to the development and function of a layered intestinal stem cell niche. Dev. Cell 58, 550–564.e6 (2023).
Shoshkes-Carmel, M. et al. Subepithelial telocytes are an important source of Wnts that supports intestinal crypts. Nature 557, 242–246 (2018).
Aoki, R. et al. Foxl1-expressing mesenchymal cells constitute the intestinal stem cell niche. Cell Mol. Gastroenterol. Hepatol. 2, 175–188 (2016).
Stzepourginski, I. et al. CD34+ mesenchymal cells are a major component of the intestinal stem cells niche at homeostasis and after injury. Proc. Natl Acad. Sci. USA 114, E506–E513 (2017).
Sailaja, B. S., He, X. C. & Li, L. The regulatory niche of intestinal stem cells. J. Physiol. 594, 4827–4836 (2016).
Eggington, H. R., Mulholland, E. J. & Leedham, S. J. Morphogen regulation of stem cell plasticity in intestinal regeneration and carcinogenesis. Dev. Dyn. 251, 61–74 (2022).
Kim, T.-H., Escudero, S. & Shivdasani, R. A. Intact function of Lgr5 receptor-expressing intestinal stem cells in the absence of Paneth cells. Proc. Natl Acad. Sci. USA 109, 3932–3937 (2012).
Farin, H. F., Van Es, J. H. & Clevers, H. Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology 143, 1518–1529.e7 (2012).
Degirmenci, B., Valenta, T., Dimitrieva, S., Hausmann, G. & Basler, K. GLI1-expressing mesenchymal cells form the essential Wnt-secreting niche for colon stem cells. Nature 558, 449–453 (2018).
Yan, K. S. et al. Non-equivalence of Wnt and R-spondin ligands during Lgr5+ intestinal stem-cell self-renewal. Nature 545, 238–242 (2017).
Zhang, Y. & Que, J. BMP signaling in development, stem cells, and diseases of the gastrointestinal tract. Annu. Rev. Physiol. 82, 251–273 (2020).
Berková, L. et al. Terminal differentiation of villus tip enterocytes is governed by distinct Tgfβ superfamily members. EMBO Rep. 24, e56454 (2023).
Lin, M. et al. Establishment of gastrointestinal assembloids to study the interplay between epithelial crypts and their mesenchymal niche. Nat. Commun. 14, 3025 (2023). The authors establish a colon assembloid system composed of epithelial and mesenchymal cells that self-organize into structures that recapitulate in vivo crypt architecture and niche interactions.
Beumer, J. et al. BMP gradient along the intestinal villus axis controls zonated enterocyte and goblet cell states. Cell Rep. 38, 110438 (2022).
Beumer, J. et al. Enteroendocrine cells switch hormone expression along the crypt-to-villus BMP signalling gradient. Nat. Cell Biol. 20, 909–916 (2018).
Lemmetyinen, T. T. et al. Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth. Dis. Model. Mech. 16, dmm049692 (2023).
Jardé, T. et al. Mesenchymal niche-derived neuregulin-1 drives intestinal stem cell proliferation and regeneration of damaged epithelium. Cell Stem Cell 27, 646–662.e7 (2020).
Holloway, E. M. et al. Mapping development of the human intestinal niche at single-cell resolution. Cell Stem Cell 28, 568–580.e4 (2021).
Deng, M. et al. Lepr+ mesenchymal cells sense diet to modulate intestinal stem/progenitor cells via Leptin–Igf1 axis. Cell Res. 32, 670–686 (2022).
Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575–579 (2021).
Thomson, C. A. et al. Expression of the atypical chemokine receptor ACKR4 identifies a novel population of intestinal submucosal fibroblasts that preferentially expresses endothelial cell regulators. J. Immunol. 201, 215–229 (2018).
Worthley, D. L. et al. Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell 160, 269–284 (2015).
Melissari, M.-T. et al. Col6a1+/CD201+ mesenchymal cells regulate intestinal morphogenesis and homeostasis. Cell. Mol. Life Sci. 79, 1 (2022).
Mulholland, E. J. et al. Epithelial GREMLIN1 disrupts intestinal epithelial-mesenchymal crosstalk to induce a wnt-dependent ectopic stem cell niche through stromal remodelling. Nat. Commun. 16, 5167 (2025). This study demonstrates how BMP disruption can trigger stromal remodelling, leading to the formation of an ectopic stem cell niche that predisposes to tumour formation.
Ouahoud, S. et al. Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp development. J. Gastroenterol. 58, 25–43 (2023).
Wang, Y. et al. Stromal BMP signaling regulates mucin production in the large intestine via interleukin-1/17. Sci. Adv. 9, eadi1827 (2023).
Allaire, J. M. et al. Bmp signaling in colonic mesenchyme regulates stromal microenvironment and protects from polyposis initiation. Int. J. Cancer 138, 2700–2712 (2016).
Jacob, J.-M. et al. PDGFRα-induced stromal maturation is required to restrain postnatal intestinal epithelial stemness and promote defense mechanisms. Cell Stem Cell 29, 856–868.e5 (2022).
Kosinski, C. et al. Indian hedgehog regulates intestinal stem cell fate through epithelial−mesenchymal interactions during development. Gastroenterology 139, 893–903 (2010).
van Dop, W. A. et al. Loss of Indian hedgehog activates multiple aspects of a wound healing response in the mouse intestine. Gastroenterology 139, 1665–1676.e10 (2010).
van Dop, W. A. et al. Depletion of the colonic epithelial precursor cell compartment upon conditional activation of the hedgehog pathway. Gastroenterology 136, 2195–2203.e7 (2009).
Davidson, L. A. et al. Alteration of colonic stem cell gene signatures during the regenerative response to injury. Biochim. Biophys. Acta 1822, 1600–1607 (2012).
Meyer, A. R., Brown, M. E., McGrath, P. S. & Dempsey, P. J. Injury-induced cellular plasticity drives intestinal regeneration. Cell Mol. Gastroenterol. Hepatol. 13, 843–856 (2022).
Yui, S. et al. YAP/TAZ-dependent reprogramming of colonic epithelium links ECM remodeling to tissue regeneration. Cell Stem Cell 22, 35–49.e7 (2018).
Nusse, Y. M. et al. Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature 559, 109–113 (2018).
Ayyaz, A. et al. Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell. Nature 569, 121–125 (2019). This study shows how a damage-induced fetal-like state emerges after injury and undergoes YAP-dependent expansion to regenerate the LGR5+ ISC pool.
Viragova, S., Li, D. & Klein, O. D. Activation of fetal-like molecular programs during regeneration in the intestine and beyond. Cell Stem Cell 31, 949–960 (2024).
Miyoshi, H. et al. Prostaglandin E2 promotes intestinal repair through an adaptive cellular response of the epithelium. EMBO J. 36, 5–24 (2017).
de Sousa e Melo, F. & de Sauvage, F. J. Cellular plasticity in intestinal homeostasis and disease. Cell Stem Cell 24, 54–64 (2019).
Chen, L. et al. TGFB1 induces fetal reprogramming and enhances intestinal regeneration. Cell Stem Cell 30, 1520–1537.e8 (2023).
Gregorieff, A., Liu, Y., Inanlou, M. R., Khomchuk, Y. & Wrana, J. L. Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer. Nature 526, 715–718 (2015).
Kim, H.-B. et al. Prostaglandin E2 activates YAP and a positive-signaling loop to promote colon regeneration after colitis but also carcinogenesis in mice. Gastroenterology 152, 616–630 (2017).
Hartl, K. et al. p53 terminates the regenerative fetal-like state after colitis-associated injury. Sci. Adv. 10, eadp8783 (2024).
Iftekhar, A. et al. Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells. Nat. Commun. 12, 1003 (2021).
Shah, K. et al. Cell-intrinsic aryl hydrocarbon receptor signalling is required for the resolution of injury-induced colonic stem cells. Nat. Commun. 13, 1827 (2022).
Capdevila, C. et al. Time-resolved fate mapping identifies the intestinal upper crypt zone as an origin of Lgr5+ crypt base columnar cells. Cell 187, 3039–3055.e14 (2024).
Malagola, E. et al. Isthmus progenitor cells contribute to homeostatic cellular turnover and support regeneration following intestinal injury. Cell 187, 3056–3071.e17 (2024).
Azkanaz, M. et al. Retrograde movements determine effective stem cell numbers in the intestine. Nature 607, 548–554 (2022).
Cader, M. Z. & Kaser, A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 62, 1653–1664 (2013).
Palikuqi, B. et al. Lymphangiocrine signals are required for proper intestinal repair after cytotoxic injury. Cell Stem Cell 29, 1262–1272.e5 (2022).
Baghdadi, M. B. et al. Enteric glial cell heterogeneity regulates intestinal stem cell niches. Cell Stem Cell 29, 86–100.e6 (2022).
Cadinu, P. et al. Charting the cellular biogeography in colitis reveals fibroblast trajectories and coordinated spatial remodeling. Cell 187, 2010–2028.e30 (2024).
Hageman, J. H. et al. Intestinal regeneration: regulation by the microenvironment. Dev. Cell 54, 435–446 (2020).
Goto, N. et al. Lymphatics and fibroblasts support intestinal stem cells in homeostasis and injury. Cell Stem Cell 29, 1246–1261.e6 (2022).
Miyoshi, H., Ajima, R., Luo, C. T., Yamaguchi, T. P. & Stappenbeck, T. S. Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science 338, 108–113 (2012).
Koppens, M. A. J. et al. Bone morphogenetic protein pathway antagonism by Grem1 regulates epithelial cell fate in intestinal regeneration. Gastroenterology 161, 239–254.e9 (2021).
Horiguchi, H. et al. ANGPTL2 expression in the intestinal stem cell niche controls epithelial regeneration and homeostasis. EMBO J. 36, 409–424 (2017).
Harnack, C. et al. R-spondin 3 promotes stem cell recovery and epithelial regeneration in the colon. Nat. Commun. 10, 4368 (2019).
Greicius, G. et al. PDGFRα+ pericryptal stromal cells are the critical source of Wnts and RSPO3 for murine intestinal stem cells in vivo. Proc. Natl Acad. Sci. USA 115, E3173–E3181 (2018).
Roulis, M. et al. Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche. Nature 580, 524–529 (2020).
Manieri, N. A., Drylewicz, M. R., Miyoshi, H. & Stappenbeck, T. S. Igf2bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice. Gastroenterology 143, 110–121.e10 (2012).
Orzechowska-Licari, E. J., Bialkowska, A. B. & Yang, V. W. Sonic Hedgehog and WNT signaling regulate a positive feedback loop between intestinal epithelial and stromal cells to promote epithelial regeneration. Cell Mol. Gastroenterol. Hepatol. 16, 607–642 (2023).
Kapalczynska, M. et al. BMP feed-forward loop promotes terminal differentiation in gastric glands and is interrupted by H. pylori-driven inflammation. Nat. Commun. 13, 1577 (2022).
Sigal, M. et al. Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. Nature 548, 451–455 (2017).
Sigal, M. et al. R-spondin-3 induces secretory, antimicrobial Lgr5+ cells in the stomach. Nat. Cell Biol. 21, 812–823 (2019).
Heuberger, J. et al. Extrusion of BMP2+ surface colonocytes promotes stromal remodeling and tissue regeneration. Nat. Commun. 16, 4131 (2025). This study demonstrates how immune cell-derived IFNγ in colitis induces apoptotic extrusion of BMP2+ surface colonocytes, which, in turn, remodels the mesenchymal niche to promote epithelial regeneration.
Jasso, G. J. et al. Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing. PLoS Biol. 20, e3001532 (2022).
Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714–730.e22 (2019).
Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature 574, 532–537 (2019).
Blokzijl, F. et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538, 260–264 (2016).
Vermeulen, L. et al. Defining stem cell dynamics in models of intestinal tumor initiation. Science 342, 995–998 (2013).
Nicholson, A. M. et al. Fixation and spread of somatic mutations in adult human colonic epithelium. Cell Stem Cell 22, 909–918.e8 (2018).
Snippert, H. J., Schepers, A. G., van Es, J. H., Simons, B. D. & Clevers, H. Biased competition between Lgr5 intestinal stem cells driven by oncogenic mutation induces clonal expansion. EMBO Rep. 15, 62–69 (2014).
Lopez-Garcia, C., Klein, A. M., Simons, B. D. & Winton, D. J. Intestinal stem cell replacement follows a pattern of neutral drift. Science 330, 822–825 (2010).
Snippert, H. J. et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem Cells. Cell 143, 134–144 (2010).
Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012).
Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525–532 (1988).
Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
Powell, S. M. et al. APC mutations occur early during colorectal tumorigenesis. Nature 359, 235–237 (1992).
Becker, W. R. et al. Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer. Nat. Genet. 54, 985–995 (2022).
Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608–611 (2009).
Baker, A.-M. et al. Quantification of crypt and stem cell evolution in the normal and neoplastic human colon. Cell Rep. 8, 940–947 (2014).
Flanagan, D. J. et al. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer. Nature 594, 430–435 (2021).
van Neerven, S. M. et al. Apc-mutant cells act as supercompetitors in intestinal tumour initiation. Nature 594, 436–441 (2021). Together with Flanagan et al. (2021), the authors demonstrate that APC-deficient ISCs act as supercompetitors, driving the differentiation of their wild-type neighbours by secreting the WNT antagonist Notum.
van Driel, M. S. et al. Caffeine limits expansion of Apc-deficient clones in the intestine by NOTUM inhibition. Cell Mol. Gastroenterol. Hepatol. 16, 652–655 (2023).
Huels, D. J. et al. Wnt ligands influence tumour initiation by controlling the number of intestinal stem cells. Nat. Commun. 9, 1132 (2018).
Vermeulen, L. et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 12, 468–476 (2010).
Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579–591 (2004).
O’Sullivan, J., Lysaght, J., Donohoe, C. L. & Reynolds, J. V. Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments. Nat. Rev. Gastroenterol. Hepatol. 15, 699–714 (2018).
Beyaz, S. et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature 531, 53–58 (2016).
Sasaki, A. et al. Obesity suppresses cell-competition-mediated apical elimination of RasV12-transformed cells from epithelial tissues. Cell Rep. 23, 974–982 (2018).
Kim, T.-Y. et al. A high-fat diet activates the BAs–FXR axis and triggers cancer-associated fibroblast properties in the colon. Cell Mol. Gastroenterol. Hepatol. 13, 1141–1159 (2022).
Kozar, S. et al. Continuous clonal labeling reveals small numbers of functional stem cells in intestinal crypts and adenomas. Cell Stem Cell 13, 626–633 (2013).
Fischer, J. M., Schepers, A. G., Clevers, H., Shibata, D. & Liskay, R. M. Occult progression by Apc-deficient intestinal crypts as a target for chemoprevention. Carcinogenesis 35, 237–246 (2014).
Gaynor, L. et al. Crypt density and recruited enhancers underlie intestinal tumour initiation. Nature 640, 231–239 (2025).
Sadien, I. D. et al. Polyclonality overcomes fitness barriers in Apc-driven tumorigenesis. Nature 634, 1196–1203 (2024).
Thirlwell, C. et al. Clonality assessment and clonal ordering of individual neoplastic crypts shows polyclonality of colorectal adenomas. Gastroenterology 138, 1441–1454.e7 (2010).
Leystra, A. A. et al. Multi-ancestral origin of intestinal tumors: impact on growth, progression, and drug efficacy. Cancer Rep. 5, e1459 (2022).
Lu, Z. et al. Polyclonal-to-monoclonal transition in colorectal precancerous evolution. Nature 636, 233–240 (2024).
Gausachs, M. et al. Mutational heterogeneity in APC and KRAS arises at the crypt level and leads to polyclonality in early colorectal tumorigenesis. Clin. Cancer Res. 23, 5936–5947 (2017).
Yum, M. K. et al. Tracing oncogene-driven remodelling of the intestinal stem cell niche. Nature 594, 442–447 (2021). This paper provides the first evidence that mutant ISCs can outcompete their neighbours by modulating stromal cell secretions within the shared niche.
Tomlinson, I. P. M. et al. Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet. 7, e1002105 (2011).
Jaeger, E. et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat. Genet. 44, 699–703 (2012).
Batts, L. E., Polk, D. B., Dubois, R. N. & Kulessa, H. Bmp signaling is required for intestinal growth and morphogenesis. Dev. Dyn. 235, 1563–1570 (2006).
Davis, H. et al. Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche. Nat. Med. 21, 62–70 (2015).
Haramis, A.-P. G. et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303, 1684–1686 (2004).
Galandiuk, S. et al. Field cancerization in the intestinal epithelium of patients with Crohn’s ileocolitis. Gastroenterology 142, 855–864.e8 (2012).
Leedham, S. J. et al. Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. Gastroenterology 136, 542–550.e6 (2009).
Fujii, S. et al. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Gut 53, 710–716 (2004).
Chang, W.-C. L. et al. Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium. Carcinogenesis 28, 2375–2381 (2007).
Porter, R. J., Arends, M. J., Churchhouse, A. M. D. & Din, S. Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines. J. Crohns Colitis 15, 2131–2141 (2021).
Hussain, S. P. et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 60, 3333–3337 (2000).
Cheng, H., Bjerknes, M., Amar, J. & Gardiner, G. Crypt production in normal and diseased human colonic epithelium. Anat. Rec. 216, 44–48 (1986).
Zhou, R. W., Harpaz, N., Itzkowitz, S. H. & Parsons, R. E. Molecular mechanisms in colitis-associated colorectal cancer. Oncogenesis 12, 48 (2023).
Yamamoto-Furusho, J. K. & Gutierrez-Herrera, F. D. Molecular mechanisms and clinical aspects of colitis-associated cancer in ulcerative colitis. Cells 14, 162 (2025).
Kusaba, T. et al. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol. Rep. 15, 1445–1451 (2006).
Heichler, C. et al. STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis. Gut 69, 1269–1282 (2020).
Wizenty, J. et al. Gastric stem cells promote inflammation and gland remodeling in response to Helicobacter pylori via Rspo3–Lgr4 axis. EMBO J. 41, e109996 (2022).
Sharma, A., Blériot, C., Currenti, J. & Ginhoux, F. Oncofetal reprogramming in tumour development and progression. Nat. Rev. Cancer 22, 593–602 (2022).
Tape, C. J. Plastic persisters: revival stem cells in colorectal cancer. Trends Cancer 10, 185–195 (2024).
Flier, J. S., Underhill, L. H. & Dvorak, H. F. Tumors: wounds that do not heal. N. Engl. J. Med. 315, 1650–1659 (1986).
Mzoughi, S. et al. Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer. Nat. Genet. 57, 402–412 (2025).
Leach, J. D. G. et al. Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis. Nat. Commun. 12, 3464 (2021).
Reischmann, N. et al. BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation. Oncogene 39, 6053–6070 (2020).
Bala, P. et al. Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation. Sci. Adv. 9, eadf0927 (2023).
Gil Vazquez, E. et al. Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia. Cell Stem Cell 29, 1213–1228.e8 (2022). This study identifies a dynamic continuum of functionally distinct stem cell phenotypes that comprise intestinal tumours and describes how the proportion of each varies according to genetic mutations and microenvironmental cues.
Solé, L. et al. p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis. Nat. Commun. 13, 2866 (2022).
Han, T. et al. Lineage reversion drives WNT independence in intestinal cancer. Cancer Discov. 10, 1590–1609 (2020).
Cai, J., Maitra, A., Anders, R. A., Taketo, M. M. & Pan, D. β-Catenin destruction complex-independent regulation of Hippo–YAP signaling by APC in intestinal tumorigenesis. Genes Dev. 29, 1493–1506 (2015).
Qin, X. et al. An oncogenic phenoscape of colonic stem cell polarization. Cell 186, 5554–5568.e18 (2023). This work provides evidence that cell-extrinsic and cell-intrinsic factors can distinctly shape stem cell fate polarization in colonic tumours using human organoid cultures.
Rehman, S. K. et al. Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy. Cell 184, 226–242.e21 (2021).
Álvarez-Varela, A. et al. Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy. Nat. Cancer 3, 1052–1070 (2022).
Ramos Zapatero, M. et al. Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responses. Cell 186, 5606–5619.e24 (2023).
Tauriello, D. V. F. et al. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 554, 538–543 (2018).
Rahrmann, E. P. et al. The NALCN channel regulates metastasis and nonmalignant cell dissemination. Nat. Genet. 54, 1827–1838 (2022).
Paget, S. The distribution of secondary growths in cancer of the breast. Lancet 133, 571–573 (1889).
Fumagalli, A. et al. Plasticity of Lgr5-negative cancer cells drives metastasis in colorectal cancer. Cell Stem Cell 26, 569–578.e7 (2020).
Ganesh, K. et al. L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer. Nat. Cancer 1, 28–45 (2020).
Cañellas-Socias, A. et al. Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells. Nature 611, 603–613 (2022).
de Sousa, E., Melo, F. et al. A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer. Nature 543, 676–680 (2017).
Heinz, M. C. et al. Liver colonization by colorectal cancer metastases requires YAP-controlled plasticity at the micrometastatic stage. Cancer Res. 82, 1953–1968 (2022).
Moorman, A. et al. Progressive plasticity during colorectal cancer metastasis. Nature 637, 947–954 (2025).
Cheung, P. et al. Regenerative reprogramming of the intestinal stem cell state via hippo signaling suppresses metastatic colorectal cancer. Cell Stem Cell 27, 590–604.e9 (2020).
Peinado, H. et al. Pre-metastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer 17, 302–317 (2017).
Er, E. E. et al. Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization. Nat. Cell Biol. 20, 966–978 (2018).
Calon, A. et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell 22, 571–584 (2012).
Elmentaite, R. et al. Cells of the human intestinal tract mapped across space and time. Nature 597, 250–255 (2021).
Onesto, M. M., Kim, J. & Pasca, S. P. Assembloid models of cell-cell interaction to study tissue and disease biology. Cell Stem Cell 31, 1563–1573 (2024).
Özkan, A., LoGrande, N. T., Feitor, J. F., Goyal, G. & Ingber, D. E. Intestinal organ chips for disease modelling and personalized medicine. Nat. Rev. Gastroenterol. Hepatol. 21, 751–773 (2024).
Kim, J.-E. et al. Single cell and genetic analyses reveal conserved populations and signaling mechanisms of gastrointestinal stromal niches. Nat. Commun. 11, 334 (2020).
Muhl, L. et al. Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination. Nat. Commun. 11, 3953 (2020).
Schmitt, M. & Greten, F. R. The inflammatory pathogenesis of colorectal cancer. Nat. Rev. Immunol. 21, 653–667 (2021).
de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374–403 (2023).
Huycke, T. R. et al. Patterning and folding of intestinal villi by active mesenchymal dewetting. Cell 187, 3072–3089.e20 (2024).
Shyer, A. E., Huycke, T. R., Lee, C., Mahadevan, L. & Tabin, C. J. Bending gradients: how the intestinal stem cell gets its home. Cell 161, 569–580 (2015). This study demonstrates how mechanical buckling of the epithelium during development creates pockets of mesenchymal signals that restrict ISC fate to the crypt base.
Shyer, A. E. et al. Villification: how the gut gets its villi. Science 342, 212–218 (2013).
Chin, A. M., Hill, D. R., Aurora, M. & Spence, J. R. Morphogenesis and maturation of the embryonic and postnatal intestine. Semin. Cell Dev. Biol. 66, 81–93 (2017).
Walton, K. D. et al. Villification in the mouse: Bmp signals control intestinal villus patterning. Development 143, 427–436 (2015).
Acknowledgements
F.J.E. was supported by a Foulkes Foundation Fellowship. M.S. was supported by the ERC (St Grant REVERT, 101040453) and the BMBF Consortium PACETHERAPY (01EJ2206A). S.J.L. was supported by a CRUK Program Grant (DRCNPG-Jun22\100002) and the CRUK Strategic Award CRC-STARS (SEBCRCS-2024/100001).
Author information
Authors and Affiliations
Contributions
The authors contributed equally to researching data for the article, discussion of the content and writing the article. M.S. and S.J.L. reviewed and/or edited the manuscript before submission.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Gastroenterology & Hepatology thanks Ramesh Shivdasani, Doug Winton and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
England, F.J., Lin, M., Sigal, M. et al. Defining the mucosal ecosystem: epithelial–mesenchymal interdependence in gastrointestinal health and disease. Nat Rev Gastroenterol Hepatol (2025). https://doi.org/10.1038/s41575-025-01113-4
Accepted:
Published:
DOI: https://doi.org/10.1038/s41575-025-01113-4